Aquired hemophilia A as a cause of postoperative bleeding;Erworbene hämophilie A als postoperative blutungskomplikation

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 38, Issue 5, 2003, Pages 359-365

  Leimkühler, Klaus ^a,b   Bach, F ^a   Kobert, K ^a   Korth, M ^a   Schmidt, B ^a   Kulbe, C ^a   Gummelt, I ^a   Mertzlufft, F ^a  

^a Krankenanstalten Gilead gGmbH   (Germany)

^b Krankenanstalten Gilead gGmbH   (Germany)

Author keywords

Factor VIII; Hemophilia; Inhibitors; Postoperative bleeding; rFVIIa

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; FRESH FROZEN PLASMA; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; ARGIPRESSIN[1 DEAMINO]; BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN;

ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; HEMOPHILIA A; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; INTENSIVE CARE; INTERVERTEBRAL DISKECTOMY; LAPAROTOMY; LUMBAR DISK; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; RETROPERITONEAL HEMATOMA; BLOOD CLOTTING TEST; HEMATOMA; MALE; MIDDLE AGED; PLASMA; POSTOPERATIVE COMPLICATION;

BLOOD COAGULATION TESTS; DEAMINO ARGININE VASOPRESSIN; DISKECTOMY; FACTOR VIIA; FACTOR VIII; HEMATOMA; HEMOPHILIA A; HUMANS; INTENSIVE CARE; LAPAROTOMY; MALE; MIDDLE AGED; PLASMA; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN TIME; RECOMBINANT PROTEINS; SHOCK, HEMORRHAGIC;

EID: 0038749394     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38919     Document Type: Article

References (21)

1. Cohen AJ, Kessler CM. Acquired inhibitors. Baillière's Clinical Haematology Vol. 9, No. 2, June 1996. London, Philadelphia, Sydney, Tokyo, Toronto: Baillière Tindall, 1996: 331-354
2. Evan NE, Majer RV. Acquired haemophilia: an important but often unrecognised cause of bleeding in elderly people. Brit Med J 1995; 311: 679
3. Franchini M, Gandini G, Aprili G. Erworbene Hämophilie A. Die Gelben Hefte 40. Frankfurt: Die Medizinische Verlagsgesellschaft Umwelt & Medizin mbH, 2000: 62-68
4. Gallistl S, Cvirn G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost 1999; 18: 245-249
5. Gerlach K, Dörges V, Fanter D, et al. Intraoperatives Management eines unerwarteten Blutdruckabfalls bei Bandscheibenoperationen. Anästhesiol Intensivmed Notfallmed Schmerzther 2000; 35: 41-44
6. Hay CRM. Acquired haemophilia. Baillière's Clinical Haematology. Vol. 11, No. 2. June 1998. London, Philadelphia, Sydney, Tokyo, Toronto: Baillière Tindall, 1998: 287-303
7. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-965
8. Hoffman M, Monroe DM. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Semin in Hematol 2001; 38 (Suppl 12): 6-9
9. Hoffman M, Monroe DM, Oliver JA, et al. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86: 1794-1801
10. Kreuz W, Auerswald G, Ehrenforth S, et al. Therapie der Hemmkörperhämophilie. Die Gelben Hefte 36. Marburg: Die Medizinische Verlagsgesellschaft mbH, 1996: 166-177
11. Kroll MH. Manual of Coagulation Disorders. Abingdon: Blackwell Science, 2001: 210-214
12. Largo R, Sigg P, von Felten A, et al. Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease. Br J Haematol 1974; 26: 129-140
13. Leitner G, Knöbl P, Urbanits S, et al. Successful treatment of an acquired factor VIII deficiency syndrome with immunoadsorption using protein a columns. Infus Ther Transfus Med 2001; 28 (Sonderheft 1): 35
14. Meili EO. Therapie bei erworbenen Inhibitoren gegen plasmatische Gerinnungsfaktoren. Stuttgart, New York: Schattauer, 2000: 44-47
15. Özsoylu S, Özer FI. Acquired factor IX deficiency. A report of two cases. Acta Haematol 1973; 50: 305-314
16. Peerlinck P, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor (letter). Throm Haemost 1999; 82: 1775-1776
17. Rosenfeld SB, Watkinson KK, Thompson BH, et al. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient (letter). Thromb Haemost 2002; 87: 925-926
18. Santagostino E, Morfini M, Rocino A, et al. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Thromb Haemost 2001; 86: 954-958
19. Schulman S, Bech Jensen M, Varon D, et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996; 75: 432-436
20. Söhngen D, Kuntz BME, Heins M, et al. Erworbene Faktor VIII: C-Hemmkörper bei Nichthämophilen. Infusionsther Transfusionsmed 1995; 22 (Suppl 1): 56
21. Traber KB, Jobes DR. Approach to the bleeding patient. In: Lake CL, Moore RA (eds). Blood: Hemostasis, Transfusion and alternatives in the perioperative period. New York: Raven Press, 1995: 213-225